Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.
Galanis E, Dooley KE, Keith Anderson S, Kurokawa CB, Carrero XW, Uhm JH, Federspiel MJ, Leontovich AA, Aderca I, Viker KB, Hammack JE, Marks RS, Robinson SI, Johnson DR, Kaufmann TJ, Buckner JC, Lachance DH, Burns TC, Giannini C, Raghunathan A, Iankov ID, Parney IF.
Galanis E, et al. Among authors: viker kb.
Nat Commun. 2024 Jan 12;15(1):493. doi: 10.1038/s41467-023-43076-7.
Nat Commun. 2024.
PMID: 38216554
Free PMC article.
Clinical Trial.